Full-Time

Senior Director Medical Affairs-Rare Disease

Posted on 10/4/2024

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$240k - $299.8kAnnually

+ Bonus + Equity Awards

Senior

Princeton, NJ, USA

Hybrid model requires in-office presence three days per week.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Requires an MD, Ph.D., PharmD, or equivalent degree.
  • Targeting 10 years of progressively experience within the pharmaceutical or biotech industry.
  • Must have rare disease experience.
  • Previous experience in preparing a rare disease product launch is strongly desired.
  • Strong strategic and execution skills.
  • Ability to work closely with HCPs in the rare disease space and provide valuable scientific exchange specifically in Rett Disease including clinical research, patient and caregiver burden, disease landscape and payer value.
  • Demonstrates complex problem-solving skills and ability to manage more complex problems within Therapeutic area or product teams.
  • Experience managing people with situational leadership skills and the ability to develop and retain talent.
  • Excellent written and oral communication skills, including strong formal presentation skills.
  • Excellent planning and organization skills.
  • Strong interpersonal skills.
  • Ability to maintain the highest degree of confidentiality and integrity, represent the company’s high ethics, moral behavior, and professionalism.
  • Demonstrated ability to maintain scientific credibility while being commercially supportive, and to communicate scientific results and effectively respond to data queries from customers and/or consultants.
  • Knowledge of scientific methods, research design and medical practices and procedures.
  • Must be able to travel.
  • Strong computer skills (Microsoft Office, etc.) and knowledge of database management (Veeva Vault, etc.).
  • Must be able to travel up to 40%.
Responsibilities
  • Provide scientific and medical leadership, including development of strategic plans, identifying specific unmet medical needs, and data gaps.
  • Lead the pre-launch preparation in concert the new product planning team.
  • Establish appropriate strategic partnerships with centers of excellence, advocacy groups and KOLs in areas of scientific interest.
  • Lead the design and execution of the medical plan and tactics including Real-World Evidence generation plans, working in close collaboration with other functional colleagues, including regulatory, commercial, and clinical development.
  • Lead efficient execution of the phase IV studies, including oversight of CROs, compliance with company’s policies and procedures, and study budget management.
  • Provide medical expertise and editorial support in the data dissemination from clinical and non-interventional studies at conferences and in medical journals.
  • Involvement with key HCPs in the exchange of scientific and medical information including Advisory Boards and presentations at national and international meetings.
  • Develop and maintain close professional relationships with Key Opinion Leaders and emerging scientific leaders in the community.
  • Assists in publication activities, including review and approval of abstracts and manuscripts, publication strategy development and collaboration with both internal and external authors.
  • Contribute in discussions with Development colleagues and ensure that MA (including HEOR) perspectives are provided and incorporated in Development plans.
  • Other duties as assigned.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these conditions while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
  • Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
  • The rise of personalized medicine aligns with Acadia's targeted therapy approach.

What critics are saying

  • Increased competition in CNS drug market may impact Acadia's market share.
  • Potential clinical trial delays could affect drug approval timelines.
  • Dependence on partnerships poses risks if collaborations face challenges or dissolve.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
  • The company has a strong R&D foundation, developing innovative small molecule drugs.
  • Acadia's strategic partnerships enhance its research capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE